-
-
-
-
-
-
-
AxoGen (AXGN): Management Meeting Highlights New Opportunity - Wedbush
-
-
-
-
-
-
-
Wedbush Maintains Neutral Rating and $85 PT on Medtronic (MDT) Following F3Q17 Results
-
-
-
-
-
-
-
Novocure (NVCR): KOL Call Indicates Optune Could Regain Momentum - Wedbush
-
-
-
-
-
-
-
Two deaths spark recall of St. Jude heart devices
-
-
-
-
-
-
-
Intuitive Surgical (ISRG) PT Raised to $755 at Wedbush
-
-
-
-
-
-
-
Intuitive Surgical (ISRG) Expects Another Year of Strong Procedure Growth - Wedbush
-
-
-
-
-
-
-
Wedbush Remains Bullish on Cardica (CRDC) Following the Appointment of New CEO Julian Nikolchev
-
68 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

